Institutional investors purchased a net $66.8 thousand shares of ICCC during the quarter ended December 2013. This may signal that the smart money is gaining interest in this company as the 7.29% of the shares outstanding that institutional investors hold is among the lowest in the Medical Specialties industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HEALTHINVEST PARTNERS AB Bought 69.6 Thousand shares of ImmuCell Corp
RENAISSANCE TECHNOLOGIES LLC Bought 1.4 Thousand shares of ImmuCell Corp
TOWER RESEARCH CAPITAL LLC Bought 783.00 shares of ImmuCell Corp